Two Sigma Advisers’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,086
Closed -$8.34K 2853
2022
Q4
$8.34K Sell
1,086
-189
-15% -$2.19K ﹤0.01% 2463
2022
Q3
$17K Buy
1,275
+1,111
+677% +$56.1K ﹤0.01% 2451
2022
Q2
$40K Sell
164
-9
-5% -$2.54K ﹤0.01% 2501
2022
Q1
$50K Sell
173
-27
-14% -$6.56K ﹤0.01% 2590
2021
Q4
$42K Sell
200
-36
-15% -$9.88K ﹤0.01% 2486
2021
Q3
$77K Sell
236
-120
-34% -$37.3K ﹤0.01% 2344
2021
Q2
$125K Buy
356
+68
+24% +$22.3K ﹤0.01% 2326
2021
Q1
$110K Sell
288
-96
-25% -$41.4K ﹤0.01% 2435
2020
Q4
$155K Sell
384
-16
-4% -$6.92K ﹤0.01% 2216
2020
Q3
$169K Buy
400
+11
+3% +$4.99K ﹤0.01% 2192
2020
Q2
$199K Buy
+389
New +$191K ﹤0.01% 2248

Other funds holding CFRX

Two Sigma Advisers's CFRX Position: Q1 2023 in Review

Two Sigma Advisers sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 1,086 shares — an estimated $8.34K sold.

Two Sigma Advisers first reported a position in CFRX in Q2 2020 and held it in 11 quarters. The position peaked at $199K in Q2 2020. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Two Sigma Advisers reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 1,086 ContraFect Corporation shares in Q1 2023, an estimated $8.34K.
  • Two Sigma Advisers first reported a position in ContraFect Corporation in Q2 2020 and held it in 11 quarters.
  • Two Sigma Advisers's ContraFect Corporation position peaked at $199K in Q2 2020.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.